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Patient Education and Counseling 57 (2005) 286–293AbstractThere are several instruments to assess how patients evaluate their medical treatment choice. These are used to evaluate decision aids. Our
objective is to investigate which psychological factors play a role when patients evaluate their medical treatment choices. A pool of 36 items
was constructed, covering concepts such as uncertainty about and satisfaction with the decision, informed choice, effective decision making,
responsibility for the decision, perceived riskiness of the choice, and social support regarding the decision. This pool was presented to patients
at high risk for breast and ovarian cancer, awaiting a genetic test result, and facing the choice between prophylactic surgery or screening.
Additional measures were assessed for validation purposes. Factor and Rasch analyses were used for factor and item selection. Construct
validity of emerging scales was assessed by relating them with the additional measures. Three factors summarised the psychological factors
concerning decision evaluation: Satisfaction–Uncertainty, Informed Choice, and Decision Control. Reliabilities (Cronbach’s a) of the three
scales were 0.79, 0.85, and 0.75, respectively. Construct validity hypotheses were confirmed. The first two scales were similar to previously
developed scales. Of these three scales, the Decision Control scale correlated most strongly with the well-being measures, was associated with
partner’s agreement and physician’s preferences as perceived by patients, and with a negative emotional reaction to the information material.
In conclusion, the Decision Control scale is a new scale to evaluate decision aids, and it appears to be rooted in health psychological theories.
# 2004 Elsevier Ireland Ltd. All rights reserved.
Keywords: Shared decision making; Decisional conflict; Decision satisfaction; Decision control; Regret; Responsibility; Rasch analyses; BRCA1/21. Introduction
An increasing number of studies evaluate the effects
of involving patients in the medical decision making* Corresponding author. Present address: Geert Grooteplein 14A, Kamer
0.10, Nijmegen, The Netherland. Tel.: +31 24 3610592/10389;
fax: +31 24 3610383.
E-mail address: p.stalmeier@mta.umcn.nl (Peep F.M. Stalmeier).
0738-3991/$ – see front matter # 2004 Elsevier Ireland Ltd. All rights reserved
doi:10.1016/j.pec.2004.07.010process [1]. Patients may be involved, for instance through
the provision of information, through values clarification,
or by helping patients to formulate their questions. A
wide array of outcomes has been used in such evaluations
including treatment choice and strength of treatment
preference, quality of life outcomes, psychological out-
comes such as anxiety, depression, and decisional conflict,
satisfaction with care, cognitive outcomes relating to
information needs, knowledge and risk perception, and.
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[2,3].
This study focusses on how patients evaluate the
treatment decision itself. In general, these decision related
outcomes are meant to assess how patients evaluate the
effects of interventions designed to increase patient
involvement in decision making, and not to distinguish
between patients.
In the study of treatment decisions in the context of
decision support interventions, two approaches have been
followed: (1) assess the patient’s evaluation of the decision
making processs [4]; and (2) assess the patient’s evaluation
of the decision. The first approach deals primarily with the
quality of the information processing. Improving informa-
tion processing is an important goal of decision support.
For example, Hollen [5] developed a taxonomy of decision
styles and decision quality inventories building on the
framework developed by Janis and Mann [6]. Related
approaches can be found in the coping literature, for
instance coping with information [7], and Decision
Styles Questionnaire [8]. It has been shown that these
concepts can mediate the effectiveness of patient informa-
tion material.
Our interest, however, is the second approach, i.e. the
evaluation of the decision by patients. Such decision related
evaluations have been found to be associated with treatment
choices [9] or treatment choice intentions [10].
Several scales have been developed: the Decisional
Conflict Scale [9], comprising the subscales Uncertainty,
and Factors Contributing to Uncertainty; the Effective
Decision Making scales; [9] the Satisfaction with Decision
scale [11], the Decision Attitude Scale [4], the Satisfaction
with decision making process questionnaire [12], the
Satisfaction with Decision Made Questionnaire [12], the
Decision Self Efficacy Scale [13] the Decision Emotional
Control scale [13], and the Decision Regret scale [14]. In
general, these scales have shown good internal reliability
(Cronbach’s a), and test–retest reliability. Evidence sup-
porting construct validity has also been reported.
While a wide array of scales exist, it is unclear to what
extent these scales assess different components of decision
evaluation. For instance, Decision Uncertainty and Satis-
faction with the Decision have generally been found to be
strongly correlated [9,11]; but whether both scales tap into
the same construct is not known. Furthermore, some scales
(e.g. the Decisional Conflict Scale) do not yield similar
factor structures when translated into other languages
[15].
Our goal is to uncover the factors underlying the
evaluation by patients of treatment decisions. It was not our
intention to translate existing scales completely or literally.
Additional concepts were considered. These concepts
emerged after reviewing the above literature [1–15], and
the decision making, social psychological, health psycho-
logical, and coping literatures. The following concepts were
identified: (1) affective evaluation including uncertainty andsatisfaction with the decision; (2) informed choice; (3)
effective decision making; (4) responsibility, blame,
control; (5) perceived riskiness; (6) social support and
social approval. The last three concepts are not covered
by existing scales. Responsibility was added because it
may affect treatment compliance. Responsibility may
modify feelings of regret, which in turn affects decision
making [16]. Avoiding blame for future accidents is also
believed to affect decision making [17]. Sense of control
is believed to affect health outcomes [18]. Perceived
riskiness was included because risk is a major dimension in
decision making [19]. Social support was included because
of its importance in models for health behavior and
stress.2. Methods
2.1. Item construction
The decision items were developed in Dutch by one of us
(PFMS). Some of the items were from existing scales, new
items were developed for the additional concepts. We
considered items from the studies discussed above and a
questionnaire kindly provided by Broadstock and Michie
[20]. Items were shortened or adapted to get brief
unambiguous items. All items were presented to three
investigators, of whom two investigated medical decision
making from the patients perspective, the third was an
expert in questionnaire construction. Items were discarded
when they were deemed insufficiently clear or indicative of
the concept they were meant to operationalise. Refinement
of this process took place in two extra rounds. As a result,
36 items came up. A five-point response scale ranging
from ‘strongly disagree’ (1) to ‘do not agree/do not
disagree’ (3) to ‘strongly agree’ (5) was used. A complete
list of concepts and items is available, also in Dutch, from
the first author.
2.2. Study population
The study was implemented in the Family Cancer Clinics
of the University Hospitals of Nijmegen, Groningen, and
Maastricht in the Netherlands. Both women with and
without breast/ovarian cancer who had chosen to undergo
DNA-testing were eligible.
2.3. Procedure
Original study aims and detailed methods have been
published elsewhere [21,22]. Questionnaires were sent at
baseline, T1, that is after blood sampling to test for a
BRCA1/2 mutation, at T2, 4 weeks after blood sampling, at
T3, 2 weeks after a positive test result and at T4, 3 months
after a positive test result. Half of the women received a
video and brochure [21], dealing with the decision between
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2 weeks after the blood sample, together with a follow-up
questionnaire to evaluate this information. The outcome
measures have been decribed in full detail [21,22]. A brief
summary is given below.
2.4. Measures
2.4.1. Well-being
Data were collected at all time points on anxiety (STAI)
[23], depression (CES-D) [24], and intrusive and avoidance
thoughts about cancer in the family (the Impact of Event
Scale) [25], and general health during the last week.
2.4.2. Treatment choice
At T2, women were asked what treatment was chosen
related to breast cancer risk. The choice was between
‘‘prophylactic mastectomy’’, ‘‘breast cancer screening’’,
and ‘‘undecided’’. Women were instructed to imagine that
they carried the mutation, while answering the items.
2.4.3. Strength of treatment preference
Strength of treatment preference was asked for the
treatment options prophylactic mastectomy and screening
on a four-point scale (1 = weak preference; 4 = very strong
preference). When treatment choice was ‘‘undecided’’, a
value of zero (no preference) was assigned.
2.4.4. Decision items
The items were asked before (T2) the genetic test result.
In the instruction preceding the items, it was made clear that
the items pertained to the choice between prophylactic
mastectomy and intensive screening for breast cancer.
Women were instructed to imagine they carried the
mutation, while they answered the items. Prophylactic
mastectomy or breast screening was printed in capitals
directly above the items on each of the two pages holding the
36 items. Decision items were also asked at T4.
2.4.5. Perceived strength of preference of the specialists
At T4, women were asked whether they felt that the
specialists held a treatment preference (yes/no) regarding
treatment for breast cancer, and, if so, its strength (1 = weak
preference; 2 = strong preference). If no preference was felt
to be present, a value of zero was assigned.
2.4.6. Partner agreement
Whether or not partner agreed with their choice was
asked at T1, using a seven-point response scale ranging from
strongly disagree to strongly agree.
2.4.7. Subjective knowledge
Women were asked to rate their knowledge about
prophylactic mastectomy, breast cancer screening, breast
self-examination, prophylactic oophorectomy, and ovarian
cancer screening.2.4.8. Amount of information
The amount of received information for the decision
related to breast cancer risk was also measured.
2.4.9. Satisfaction with quality of information
Women were offered a series of 13 items on the quality
of information regarding cancer risks, efficacy of treat-
ment options, and physical, emotional, and social con-
sequences.
2.4.10. Negative emotional reaction to information
material
Women evaluated the brochure and video with three
items asking about unpleasant, shocking, and frightening
experiences with this material.
2.4.11. Need for support/advice
At T4, women were asked whether they had wanted more
support and advice from their specialists regarding their
treatment choice on a seven-point scale (1 = strongly
disagree; 7 = strongly agree).
2.5. Analyses
The psychometric analyses on the decision items were
done on the data obtained at T2. When women had no
breasts because of previous curative or prophylactic surgery,
answers to decision related questions were coded as not
applicable. We did missing data analyses on the decision
items. Factor analyses were done to uncover factors
underlying decision evaluation. As factors were expected
to be associated, an oblique factor solution was sought in
order to arrive at a simple structure solution, discarding
items that loaded highly on more than one scale. For the
Rasch and Reliability analyses, items were recoded to obtain
positive correlations among items. Rasch analyses were
done on the items belonging to a single factor [26]. As Rasch
models are only readily available for dichotomous items, all
items were dichotomised by assigning the first three
response categories to 0, and the two upper categories to
1. Based on the final item selection, scores of the items were
averaged for each of the three scales. Reliability coefficients
(Cronbach’s a) were calculated. Tests of construct validity
were performed by testing hypothesised associations of the
Decision Evaluation scales with other measures described
above. These hypotheses were generated after the scales
were identified but before the relation of the scales with the
remaining measures was inspected. We tested hypotheses
cross-sectionally regarding the data collected at T2 and also
in mutation carriers at T4.
For missing items from multi-item scales, we imputed the
mean of the remaining items when at least half of the items
were completed.
The number of subjects providing data for the various
analyses varied due to missing data and due to non-
applicability of some questions.
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3.1. Number of participants
At study entrance (T1), 453 women were eligible and 390
(86%) gave informed consent [18]. By T2, 368 were still in
the study [21]. Ninety-one women had a BRCA1/2 mutation
and were therefore eligible for the second part of the study.
Three woman withdrew after the positive genetic test result
due to high emotional distress. The follow-up at T4 and T5
was complete in 88 and 87 women, respectively [2,12].
3.2. Psychometric analyses
Of the 368 women at T2, 22 women were discarded as
both their breasts were already removed, either to treat breast
cancer that had developed previously to our data collection
(N = 21), or for preventive reasons (N = 1). Three other
women with completely missing data were also discarded.
Thus data of 343 women remained for psychometric
analyses. Table 1 presents their socio-demographic data.
One item ‘I wish I could stick to my decision’ was deleted
because of too many missing responses. Of the remaining 35
items, on average, 1.5% of the item responses were missing.
Out of the 343 women, 299 (87%) completely filled out theTable 1




40 or younger 148 43
41–49 104 30
50 or older 91 27
Marital status
Single 23 7






Lower than high school 75 22
High school 179 52
College or higher 82 24
Personal medical history
No cancer 172 50
Breast cancer only 153 45
Ovarian cancer only 15 4
Breast and/or ovarian cancer 3 1
Familial medical history
Breast cancer only 155 50
Ovarian cancer Only 11 4
Breast and ovarian cancer 141 46
Known familial mutation 47
First degree relatives with bc or oc 62
First degree relatives died of bc or oc 32remaining 35 items, and these were subjected to factor
analysis. An interpretable oblique solution was found
containing three factors, explaining 34, 7 and 6% of the
variance in the data from 35 items.
Items in these factors were subjected to Rasch analyses.
After further item selection, three Rasch scales emerged
containing five items each. Rasch statistics are available
from the first author. These 15 items were translated into
English independently by the first author and a professional
translator. Discrepancies between the translations were
resolved by consensus. In view of the item content and the
factor loadings, these scales were labelled as Satisfaction–
Uncertainty, Informed Choice, and Decision Control. Higher
scores on the Satisfaction–Uncertainty scale indicate higher
Satisfaction, and thus lower uncertainty. The reliabilities
(Cronbach’s a) of the three scales were 0.79, 0.85, and 0.75,
respectively.
The factor analyses on the final item selection is presented
in Table 2. The three scales explained 39, 12, and 8% of the
total variance of the final 15 items. For each scale, scale
values were calculated when responses on three or more
items were present. Each scale value was available for at least
96% of the 343 women. The correlations between the scales
were moderate (Satisfaction–Uncertainty, Informed Choice)
= 0.52, r (Satisfaction–Uncertainty, Decision Control) = 0.56,
r (Informed Choice, Decision Control) = 0.41.
Our prior concepts appear to have been only partly
confirmed, as the concepts social support and approval,
effective decision making, and perceived riskiness were not
retained in the final Decision Evaluation scales. When we
allowed for five factors to be extracted (results not shown),
social support and perceived riskiness items did yield two
additional factors. However, these factors added relatively
little to the explained variance of the variables in the Factor
analysis, and were therefore not retained. In three factor
solutions, the items constructed to cover the concepts of
social support, responsibility, and effective decision making
blended with the factor Satisfaction–Uncertainty. The social
support items did not survive further item selection
procedures. The perceived riskiness items were correlated
with the Decision Control scale, but also did not survive
further item selection procedures. Thus, we conclude that
there was some evidence for the prior concepts, but these
concepts explained little additional variance, and blended
with the Satisfaction–Uncertainty or Decision Control
factors.
3.3. Validity
The scales should be associated with Strength of
Preference regarding the treatment choices for breast cancer.
Higher Strength of Preference was expected to be associated
with higher Satisfaction–Uncertainty, Informed Choice, and
Decision Control scores. The results in Table 3, row 1,
support these hypotheses. Sample sizes varied from 302 and
328.
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Table 2
Factor loadings (Pattern Matrix) of 15 items in 3 Rasch scales, obtained after oblique rotation
Satisfaction–Uncertainty Informed Choice Decision Control
I expect to stick with my decision 0.83
I am satisfied with my decision 0.82
I am still doubtful about my choice 0.76
This is my own decision 0.66
I find it hard to make this choice 0.60
I am satisfied with the information I received 0.83
I know the pros and cons of the treatments 0.78
I want more information about this decision 0.76
I want a clearer advice 0.70
I made a well informed choice 0.41 0.62
This decision is made without me 0.84
I feel pressure from others in making this decision 0.74
I wish someone else would decide for me 0.58
My decision frightens me 0.29 0.26 0.45
I regret my decision 0.41 0.43
*Correlations smaller than 0.25 are suppressed.We hypothesised that Satisfaction–Uncertainty, Informed
Choice, and Decision Control were associated with
improved well-being. The results in Table 3 confirm these
hypotheses. Decision Control showed the largest associa-
tions with well-being.
We hypothesised that the scales should be associated with
three the information related measures. We expected that
better scores on the three information related measures
should be associated with higher Satisfaction–Uncertainty,
Informed Choice, and Decision Control scores. The
associations should also be stronger for the Informed
Choice scale. The results in Table 3, rows 6–8, support these
hypotheses.
Previously, we found [27] that a negative emotional
reaction to a similar video and brochure was associated with
a more troublesome resolution of decision process. We
expected that lower scores on Decision Evaluation scales
would be related to a negative emotional reaction towards
the brochure and video. This turned out to be the case,Table 3
Correlations of Satisfaction–Uncertainty, Informed Choice, and Decision control, w
T2, 4 weeks after blood sampling
Satisfaction–Uncertain






Amount of information 0.27
Satisfaction with quality of information 0.23
Negative emotional reaction 0.19*
Partner agreement 0.27
All remaining P-values < 0.001.
* P < 0.02.Table 3, row 9. Decision Control showed the largest asso-
ciation with a negative emotional reaction to the information
material. Sample sizes vary from 161 to 163 because these
data are from the intervention group.
Women were asked whether the partner agreed with their
treatment choice. We expected that partner agreement would
have a positive effect on the decision evaluation. These
hypotheses were also confirmed (Table 3, row 10). For row
10, N varies from 264 to 268, because not all women had a
partner.
Table 4 presents mean scores on the scales split out by
treatment choice. Decision Evaluation scores were worse in
undecided women, (Satisfaction–Uncertainty, F(2,325) =
30.89, P < .0001; Informed Choice, F(2,323) = 4.35, P =
0.014; Decision Control, F(2,325) = 8.33, P = 0.003).
After disclosure of the genetic test result, we asked
whether more support or a clearer advice from the physician
was needed. We expected lower Satisfaction–Uncertainty,
Informed Choice, and Decision Control scores if womenith Strength of Preference, information related and well-being measures, at
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Table 4
Mean scores (standard deviations) for Decision evaluation scales 4 weeks after blood sampling, for all women, and split out by treatment choice
Satisfaction–Uncertainty Informed Choice Decision Control
Entire population 3.63 (0.70) 3.14 (0.78) 2.97 (0.64)
Prophylactic mastectomy 3.74 (0.60) 3.14 (0.77) 3.02 (0.62)
Screening for BC 3.71 (0.69) 3.21 (0.81) 3.01 (0.64)
Undecided 2.73 (0.40) 2.76 (0.54) 2.51 (0.62)
Responses range from 1 = ‘strongly disagree’ to 5 = ‘strongly agree’. BC: Breast cancer. Across the three Decision evaluation scales, sample sizes vary from 326
to 328 for the entire population, 121 to 124 for Prophylactic mastectomy, 174 to 178 for screening for BC, and 20 to 30 for undecided.
Table 5
Correlations of Decision evaluation scales with need for support and advice, and perceived Strength of preference of physicians, 3 months after a positive test
result
Need for support/advice Perceived strength of preference of physicians
Satisfaction–Uncertainty 0.36** 0.06
Informed Choice 0.56** 0.06
Decision Control 0.59** 0.30**
N-sizes vary from 69 to 77.
** P < 0.004.indicated the need for more support/advice. The results are
presented in Table 5, column 2. The results support our
hypotheses.
We also asked whether women perceived the specialists
as holding strong treatment preferences. If so, this should be
associated with feelings of pressure, one of the items in the
Decision Control scale. The results in Table 5, column 3,
support this hypothesis, and for the first time provide support
for divergent validity of the Decision Control scale as
compared to the other two Decision Evaluation scales.4. Discussion and conclusion
We set out to uncover the dimensions involved in the
evaluation of medical decisions from the patient perspective.
We uncovered a new concept measured by the Decision
Control scale. We confirmed previously uncovered dimen-
sions such as Satisfaction–Uncertainty and Informed
Choice.
We discuss first the Decision Control Scale. Control is a
central concept in the health psychology literature [18], and
thus, in retrospect, the emergence of this concept in the
evaluation of medical decisions is not surprising. The
separate items of the Decision Control scale suggest that
feelings of regret, anxiety, and feeling of being put under
pressure occur in women that are low in Decisional Control.
Undecided women reported lower levels of Decision
Control. In line with findings that control may be a resource
that aids in resisting stress [28], Decision Control was the
strongest predictor of well-being. Women who were low in
control proclaimed a strong need for additional support and
treatment advice, however (and paradoxically), such women
also showed a strong negative reaction towards the
information material.In general, control is viewed as [28] ‘‘a measure of
relatively stable, cross-situational individual differences ...’’
in other words, as a a relatively stable personality trait or
disposition. Regret is one of the items in our Decision
Control scale. A dispositional interpretation sheds a
different light on previous studies on regret in medical
decision making. Brehaut et al. [14] found that women with
stronger regret switched treatments more often. We find that,
even before treatment was received, undecided women have
lower levels of Decision Control, and thus higher levels of
regret. Likewise, in a retrospective study, Borgen et al. [29]
studied feelings of regret in 370 women who underwent
prophylactic bilateral mastectomy. Feelings of regret were
4.26 times more likely when women reported that the
discussion about prophylactic mastectomy was initiated by
the physician. We found a remarkably similar association:
feelings of regret were 5.03 times more likely when women
reported pressure from others (another item in the Decision
Control scale). But again, this association existed before the
genetic test result was known, that is long before these
women convened with the specialists, and thus long before
surgery was performed. This analysis suggests that regret
studies should consider prospective longitudinal study
designs to control for dispositional explanations.
Associations between some of the items in our Decision
Control scale have been reported previously, thus providing
independent support for the validity of this scale. Brehaut et
al. [14] developed a regret scale and noted that higher regret
occurred in those who preferred their physicians to make
decisions. We confirm this association as regret is in our
Decision Control scale as well as two items that deal with
whether or not the decision is transferred to someone else.
Another item in our scale, ‘I wish someone else would
decide for me’ was similar to an item used by Sainfort and
Booske [4]. He found that this item was not associated with
decision satisfaction, and concluded that ‘‘the notion of
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an important and independent element of decision satisfac-
tion’’. His conclusion is corroborated by our finding that the
Decision Control scale, that contained this item, was an
additional factor of decision evaluation.
In contrast to previous findings, we found that items from
existing uncertainty, satisfaction, and effective decision
making scales are located on a single scale. We believe that
this finding is not really at odds with previous findings. For
instance, three reports [4,9,11] examined uncertainty and
satisfaction. O’Connor reported strong correlations between
the effective decision making and uncertainty scales, up to
0.66. In Sainfort and Booske [4], one of the items loading on
the ‘satisfaction with choice’ scale, namely ‘it was difficult
to make a choice’, is similar to the item ‘this decision is hard
for me to make’, but the latter item figures in O’Connor’s
uncertainty scale. Also, Holmes noted a correlation of 0.54
between satisfaction and uncertainty.
4.1. Limitations
One may question the applicability of our items to
decisions that are not final. For instance, satisfaction with a
decision (not the process of decision making) and regret are
commonly thought to be associated with experiencing good
or bad outcomes from a decision, and not with the decision
itself. The reader may therefore feel that assessing
satisfaction or regret about a decision not yet made is
premature. However, regret also occurs when one realizes
that good outcomes of a foregone option are no longer
possible, that is before outcomes are experienced [16,30].
Specifically, Brehaut et al. [14] defines decision regret ‘‘as
remorse and distress over a decision’’, and not over the
outcome. A similar distinction between decision evaluation
and outcome evaluation is made in consumer research [4],
namely between post-decision and post-purchase satisfac-
tion. In our case, for instance, consider a women who has
chosen prophylactic mastectomy and waits for surgery. She
may be coping with the future loss of her breasts. She may
regret the loss of her breasts, which she could have kept had
she chosen the foregone option of breast screening.
Furthermore, the data suggested that few women experi-
enced problems answering our satisfaction and regret
questions. The satisfaction and regret items were skipped
by only 5 and 10 out of 343 women, respectively.
4.2. Practice implications
We found that Satisfaction–Uncertainty and Informed
Choice were important dimensions of decision evaluation.
The Decision Evaluation scales in turn were moderately
correlated with well-being. These associations with well-
being were even stronger after a positive test result (up to
0.53). Counselors and clinicians should therefore consider to
refer women with low scores on the Decision Evaluation
scales to a psychologist. An easy way to check for lowDecision Evaluation scores is to ask whether a decision has
been made because undecided women (about 8%) scored
worse on the Decision Evaluation scales.Acknowledgements
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